Botulinum Toxin: A Promising Treatment for Chronic Migraine
- MigraineMind
- Nov 7, 2025
- 1 min read
Research Summary
Chronic migraine (CM), affecting sufferers on 15 or more days a month, poses a significant treatment challenge. Recent research published in the Journal of Neural Transmission highlights botulinum toxin (BoNT) as an effective treatment option, especially for those who do not respond well to standard medications or experience adverse effects. BoNT works by inhibiting the release of pain-modulating neuropeptides. Multiple randomized controlled trials have confirmed its clinical efficacy and safety, significantly reducing headache frequency in CM patients. This review offers a comprehensive look at BoNT's potential as a promising therapy for those grappling with chronic migraine.
Study Details
👥 Research Team: Paracka L, Dressler D
📚 Published In: J Neural Transm (Vienna)
📅 Publication Date: 2025 Nov 6
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.